Exchange Traded Concepts, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

$7.62 Billion
Q2 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 46,205 shares of ARWR stock, worth $822,449. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,205

Previous 49,247 6.18%

Holding current value

$822,449

Previous $627,000 16.43%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	SELL	$9.99 - $16.97 $30,389 - $51,622	-3,042 Reduced 6.18%	46,205 $730,000
Q1 2025 Apr 17, 2025	BUY	$12.74 - $21.53 $151,338 - $255,754	11,879 Added 31.79%	49,247 $627,000
Q4 2024 Jan 21, 2025	SELL	$17.7 - $26.34 $51,754 - $77,018	-2,924 Reduced 7.26%	37,368 $702,000
Q3 2024 Oct 10, 2024	SELL	$19.36 - $29.54 $168,122 - $256,525	-8,684 Reduced 17.73%	40,292 $780,000
Q2 2024 Aug 13, 2024	BUY	$21.87 - $28.24 $435,366 - $562,173	19,907 Added 68.48%	48,976 $1.27 Million
Q1 2024 Apr 15, 2024	SELL	$27.21 - $39.48 $399,524 - $579,684	-14,683 Reduced 33.56%	29,069 $831,000
Q4 2023 Jan 05, 2024	BUY	$21.2 - $31.03 $927,542 - $1.36 Million	43,752 New	43,752 $1.34 Million
Q1 2023 Apr 12, 2023	BUY	$23.68 - $38.51 $8,808 - $14,325	372 Added 0.73%	51,272 $1.3 Million
Q4 2022 Jan 17, 2023	BUY	$28.0 - $40.56 $244,272 - $353,845	8,724 Added 20.68%	50,900 $2.07 Million
Q3 2022 Oct 07, 2022	SELL	$29.63 - $48.31 $231,765 - $377,880	-7,822 Reduced 15.64%	42,176 $1.39 Million
Q2 2022 Jul 20, 2022	SELL	$27.79 - $50.61 $51,300 - $93,426	-1,846 Reduced 3.56%	49,998 $1.76 Million
Q1 2022 Apr 26, 2022	BUY	$39.62 - $69.97 $1.21 Million - $2.14 Million	30,654 Added 144.66%	51,844 $2.38 Million
Q4 2021 Jan 13, 2022	SELL	$58.09 - $82.51 $312,814 - $444,316	-5,385 Reduced 20.26%	21,190 $1.41 Million
Q3 2021 Oct 18, 2021	BUY	$58.38 - $84.96 $313,617 - $456,405	5,372 Added 25.34%	26,575 $1.66 Million
Q2 2021 Jul 30, 2021	SELL	$62.15 - $90.32 $115,909 - $168,446	-1,865 Reduced 8.08%	21,203 $1.76 Million
Q1 2021 Apr 20, 2021	BUY	$61.35 - $90.47 $1.42 Million - $2.09 Million	23,068 New	23,068 $1.53 Million

Others Institutions Holding ARWR

# of Institutions

316

Shares Held

99M

Call Options Held

444K

Put Options Held

568K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.88B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Arrowhead Pharmaceuticals, Inc. Transaction History